Possible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles

被引:29
|
作者
Wohlgemuth, M
Lemmers, RJ
van der Kooi, EL
van der Wielen, MJ
van Overveld, PG
Dauwerse, H
Bakker, E
Frants, RR
Padberg, GW
van der Maarel, SM
机构
[1] Univ Med Ctr Nijmegen, Dept Neurol, NL-6500 HB Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands
关键词
D O I
10.1212/WNL.61.7.909
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Autosomal dominant facioscapulohumeral muscular dystrophy ( FSHD) is associated with a contraction of the D4Z4 repeat array on chromosome 4. So far, homozygosity or compound heterozygosity for FSHD alleles has not been described, and it has been debated whether the absence of such subjects is because of the rarity or the lethality of the disorder. Methods: Two unrelated families in which the probands are compound heterozygous for two FSHD-sized alleles were studied. Clinical examination, pulsed-field gel electrophoresis (PFGE) studies of DNA with probes proximal and distal to D4Z4, and cytogenetic analysis of metaphase chromosomes by FISH were performed. Results: Complementary molecular and cytogenetic approaches confirmed the chromosome 4qA origin of all FSHD-sized repeat arrays that segregate in the families. Conclusions: Heterozygosity for FSHD-sized alleles is compatible with life in men and women. A possible dosage effect was observed in both probands in whom each 4qA allele contributed to the FSHD phenotype. Because at least one of the FSHD alleles in both families showed an unusual low penetrance, the authors propose that susceptibility for FSHD is partly determined by intrinsic properties of the disease allele other than the residual D4Z4 repeat size alone.
引用
收藏
页码:909 / 913
页数:5
相关论文
共 8 条
  • [1] Altered DNA methylation at 4q35 in FSHD patients
    Balog, J
    Pikó, H
    Karcagi, V
    FEBS JOURNAL, 2005, 272 : 119 - 120
  • [2] FSHD-like patients without 4q35 deletion
    Yamanaka, G
    Goto, K
    Ishihara, T
    Oya, Y
    Miyajima, T
    Hoshika, A
    Nishino, I
    Hayashi, YK
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 219 (1-2) : 89 - 93
  • [3] Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion
    Krasnianski, M
    Neudecker, S
    Eger, K
    Jakubiczka, S
    Zierz, S
    JOURNAL OF NEUROLOGY, 2003, 250 (09) : 1084 - 1087
  • [4] Clinical and histopathological heterogeneity in patients with 4q35 facioscapulohumeral muscular dystrophy (FSHD)
    Wood-Allum, C
    Brennan, P
    Hewitt, M
    Lowe, J
    Tyfield, L
    Wills, A
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2004, 30 (02) : 188 - 191
  • [5] Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion
    Michael Krasnianski
    Stephan Neudecker
    Katharina Eger
    Sibylle Jakubiczka
    Stephan Zierz
    Journal of Neurology, 2003, 250 : 1084 - 1087
  • [6] Genetic and disease analysis of FSHD-linked 4q35 region in female Coats Disease patients
    Fitzsimons, R.
    Jones, P.
    Fung, A.
    Jones, T.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S52 - S52
  • [7] CORRELATION BETWEEN FRAGMENT SIZE AT D4F104S1 AND AGE AT ONSET OR AT WHEELCHAIR USE, WITH A POSSIBLE GENERATIONAL-EFFECT, ACCOUNTS FOR MUCH PHENOTYPIC VARIATION IN 4Q35-FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD)
    LUNT, PW
    JARDINE, PE
    KOCH, MC
    MAYNARD, J
    OSBORN, M
    WILLIAMS, M
    HARPER, PS
    UPADHYAYA, M
    HUMAN MOLECULAR GENETICS, 1995, 4 (05) : 951 - 958
  • [8] CORRELATION BETWEEN FRAGMENT SIZE AT D4F104S1 AND AGE AT ONSET OR AT WHEELCHAIR USE, WITH A POSSIBLE GENERATIONAL-EFFECT, ACCOUNTS FOR MUCH PHENOTYPIC VARIATION IN 4Q35-FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY (FSHD) (VOL 4, PG 951, 1995)
    LUNT, PW
    JARDINE, PE
    KOCH, MC
    MAYNARD, J
    OSBORN, M
    WILLIAMS, M
    HARPER, PS
    UPADHYAYA, M
    HUMAN MOLECULAR GENETICS, 1995, 4 (07) : 1243 - 1244